Dermatofibrosarcoma Protuberans — Trials

Dermatofibrosarcoma Protuberans — Trials · CancerIndex

Clinical trials

Registered studies

16 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01962103	Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors	completed	Phase 1 / Phase 2	107	CelgeneINDUSTRY	7	Dec 27, 2019	clinicaltrials
NCT01154452	Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma	completed	Phase 1 / Phase 2	78	National Cancer Institute (NCI)NIH	1	Aug 15, 2018	clinicaltrials
NCT00720174	Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma	completed	Phase 1	30	National Cancer Institute (NCI)NIH	1	May 17, 2016	clinicaltrials
NCT00122473

Data updated 22 days agoSource updated Dec 27, 2019source: clinicaltrials